- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01964898
Post Acute Coronary Event Smoking Study (PACES)
Integrated Smoking Cessation and Mood Management for Cardiac Patients
Studie Overzicht
Toestand
Gedetailleerde beschrijving
The occurrence of Acute Coronary Syndrome (ACS; unstable angina, ST and non-ST elevation myocardial infarction) can be conceptualized as a "teachable moment," whereby patients may be more receptive to smoking cessation messages. Continued smoking following ACS is an independent predictor of mortality. Depressed mood post-ACS is also predictive of mortality, and smokers with depressed mood are less likely to abstain from smoking following an ACS hospitalization. Thus, a single, integrated treatment that targets both depressed mood and smoking could be highly effective in reducing post-ACS mortality. Behavioral Activation (BA) may be an ideal treatment for this population as BA can easily integrate both mood and smoking cessation related goals and it focuses on addressing restriction of valued activities, which is common in the post-ACS population.
Thus, the overall aim of the current study is test a BA treatment manual that integrates smoking cessation and mood management for post-ACS smokers (Behavioral Activation Treatment for cardiac patients who smoke; BAT-CS). We will conduct an RCT (N=72) comparing BAT-CS (1 in-hospital session and 5-9 post-discharge sessions) to Standard Care (SC; 1 in-hospital session and 5 mailed packets of printed self-help materials). Differences in smoking cessation, depressed mood, and positive affect will be compared between conditions.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Rhode Island
-
Providence, Rhode Island, Verenigde Staten, 02903
- The Miriam Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- ACS diagnosis documented in medical record
- smoked 3 or more cigarettes per day before being hospitalized
- between the ages of 18-75
- fluent in English
- regular access to a telephone
- lives in the Providence, RI area
- willing to "strongly consider" an attempt to quit smoking at discharge
Exclusion criteria:
- limited mental competency (i.e., Mini-Mental Status exam < 20)
- presence of current psychosis, serious mental illness, or suicidality, expectation that patient will not live through 6 month study period
- currently regularly attending counseling for depression or smoking cessation and plans to continue after discharge
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: BA for cardiac patients who smoke
Behavioral Activation Treatment for cardiac patients who smoke (BAT-CS).
Participant will receive (a) 1 hour of standard smoking cessation counseling in the hospital and (b) 5 to 9 Behavioral Activation (BA) counseling sessions focused on cessation and mood management after they leave the hospital.
BA sessions will occur over the 12 weeks after hospital discharge.
An 8 week supply of the nicotine patch will be provided if the patient is cleared by their MD.
|
5 to 9 Behavioral Activation (BA) counseling sessions focused on cessation and mood management.
BA sessions will occur over the 12 weeks after hospital discharge.
1 hour of in hospital counseling based on clinical guidelines
An 8 week supply of the nicotine patch will be provided if the patient is cleared by their MD.
|
Actieve vergelijker: Standard Care
Participant will receive (a) 1 hour of standard smoking cessation counseling in the hospital and (b) 5 packets of printed self-help materials for smoking cessation mailed 1, 3, 6, 9, and 12 weeks after hospital discharge.
An 8 week supply of the nicotine patch will be provided if the patient is cleared by their MD.
|
1 hour of in hospital counseling based on clinical guidelines
An 8 week supply of the nicotine patch will be provided if the patient is cleared by their MD.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Smoking Cessation: 7 Day Point Prevalence Abstinence
Tijdsspanne: 6 months
|
No smoking, not even a puff, for 7 days; verified by carbon monoxide measurement.
Results are adjusted for nicotine patch use and concurrent medication treatment targeting cessation.
|
6 months
|
Continuous Abstinence From Smoking Since Discharge
Tijdsspanne: 6 months
|
Results are adjusted for nicotine patch use and concurrent medication treatment targeting cessation.
|
6 months
|
Time to Smoking Relapse
Tijdsspanne: 6 months
|
Time in days to first relapse (i.e., smoking on 7 consecutive days or smoking in 2 consecutive 7 day periods), which were determined through timeline follow back interviewing.
Results are adjusted for nicotine patch use and concurrent medication treatment targeting cessation.
|
6 months
|
Time to Smoking Lapse
Tijdsspanne: 6 months
|
Time in days to first lapse (i.e., first puff of a cigarette) after discharge, which were determined through timeline follow back interviewing.
Results are adjusted for nicotine patch use and concurrent medication treatment targeting cessation.
|
6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Depression: 9 Item Patient Health Questionnaire (PHQ-9)
Tijdsspanne: Baseline to 6 months
|
The 9 item Patient Health Questionnaire (PHQ-9) ranges from 0-27 with higher scores indicating higher depression symptoms.
Adjusted for anti-depressant medication use and for cardiac rehabilitation attendance.
|
Baseline to 6 months
|
Depression: 10 Item Center for Epidemiologic Studies Depression Scale (CESD)
Tijdsspanne: Baseline to 6 months
|
The 10 item Center for Epidemiologic Studies Depression Scale ranges from 0-30 with higher scores indicating higher depression symptoms.
Adjusted for anti-depressant medication use and for cardiac rehabilitation attendance.
|
Baseline to 6 months
|
Positive Affect
Tijdsspanne: Baseline to 6 months
|
As measured by the 10 item Positive Affect Negative Affect Scales (PANAS).
The positive affect scale on the PANAS ranges from 5-25 with higher scores indicating greater positive affect in the past week.
Adjusted for anti-depressant medication use and for cardiac rehabilitation attendance
|
Baseline to 6 months
|
Negative Affect
Tijdsspanne: Baseline to 6 months
|
As measured by the 10 item Positive Affect Negative Affect Scales (PANAS).
The negative affect scale on the PANAS ranges from 5-25 with higher scores indicating greater negative affect in the past week.
Adjusted for anti-depressant medication use and for cardiac rehabilitation attendance.
|
Baseline to 6 months
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Andrew M Busch, Ph.D, The Miriam Hospital Centers for Behavioral and Preventive Medicine
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Myocardiale ischemie
- Hartziekten
- Hart-en vaatziekten
- Vaatziekten
- Acute kransslagader syndroom
- Fysiologische effecten van medicijnen
- Neurotransmitter agenten
- Moleculaire mechanismen van farmacologische werking
- Autonome agenten
- Agenten van het perifere zenuwstelsel
- Cholinerge middelen
- Ganglionische stimulerende middelen
- Nicotine-agonisten
- Cholinerge agonisten
- Nicotine
Andere studie-ID-nummers
- 5K23HL107391 (Subsidie/contract van de Amerikaanse NIH)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Stoppen met roken
-
Boston UniversityFlight Attendant Medical Research InstituteVoltooid
-
Cedars-Sinai Medical CenterUniversity of California, San FranciscoVoltooidTweedehands smoking | Vasculaire verouderingVerenigde Staten
-
Peking Union Medical College HospitalRun Shaw Hospital, Zhejiang University School of Medicine; Hangzhou Medisol Technology...Nog niet aan het wervenTweedehands smoking | Passief roken | Verontreiniging door tabaksrookChina
-
Mustafa Kemal UniversityOnbekendTweedehands smokingKalkoen
Klinische onderzoeken op Behavioral Activation (BA)
-
Drexel UniversityVoltooidObesitas | OvergewichtVerenigde Staten
-
ElMindA LtdOnbekendGezond | Cognitieve beperking | Neurologische stoornisVerenigde Staten
-
BioNTech SEPfizerVoltooidCOVID-19 | SARS-CoV-2-infectieVerenigde Staten
-
Providence VA Medical CenterVoltooidDepressie | SuikerziekteVerenigde Staten
-
Korea Health Industry Development InstituteWervingZiekte van ParkinsonKorea, republiek van
-
Hacettepe UniversityVoltooidChirurgie | Rotator cuff tranenKalkoen
-
BioNTech SEPfizerIngetrokken
-
The University of Texas Health Science Center at...The Rutgers Asian Resource Center for Minority Aging Research (RCMAR)WervingType 2 diabetesVerenigde Staten
-
University of ExeterDevon Partnership NHS TrustVoltooidBipolaire depressieVerenigd Koninkrijk
-
St. Joseph's Healthcare HamiltonVoltooid